About Us

Laser Focus World is an industry bedrock—first published in 1965 and still going strong. We publish original articles about cutting-edge advances in lasers, optics, photonics, sensors, and quantum technologies, as well as test and measurement, and the shift currently underway to usher in the photonic integrated circuits, optical interconnects, and copackaged electronics and photonics to deliver the speed and efficiency essential for data centers of the future.

Our 80,000 qualified print subscribers—and 130,000 12-month engaged online audience—trust us to dive in and provide original journalism you won’t find elsewhere covering key emerging areas such as laser-driven inertial confinement fusion, lasers in space, integrated photonics, chipscale lasers, LiDAR, metasurfaces, high-energy laser weaponry, photonic crystals, and quantum computing/sensors/communications. We cover the innovations driving these markets.

Laser Focus World is part of Endeavor Business Media, a division of EndeavorB2B.

Laser Focus World Membership

Never miss any articles, videos, podcasts, or webinars by signing up for membership access to Laser Focus World online. You can manage your preferences all in one place—and provide our editorial team with your valued feedback.

Magazine Subscription

Can you subscribe to receive our print issue for free? Yes, you sure can!

Newsletter Subscription

A Laser Focus World newsletter subscription is free to qualified professionals:

The Daily Beam

Showcases the newest content from Laser Focus World, including photonics- and optics-based applications, components, research, and trends. (Daily)

Product Watch

The latest in products within the photonics industry. (9x per year)

Bio & Life Sciences Product Watch

The latest in products within the biophotonics industry. (4x per year)

Laser Processing Product Watch

The latest in products within the laser processing industry. (3x per year)

Get Published!

If you’d like to write an article for us, reach out with a short pitch to Sally Cole Johnson: [email protected]. We love to hear from you.

Photonics Hot List

Laser Focus World produces a video newscast that gives a peek into what’s happening in the world of photonics.

Following the Photons: A Photonics Podcast

Following the Photons: A Photonics Podcast dives deep into the fascinating world of photonics. Our weekly episodes feature interviews and discussions with industry and research experts, providing valuable perspectives on the issues, technologies, and trends shaping the photonics community.

Social Media

Bluesky • Facebook • Instagram • LinkedIn • YouTube

Meet the Laser Focus World Team

Editorial

Sales

Editorial Advisory Board

  • Professor Andrea M. Armani, University of Southern California
  • Ruti Ben-Shlomi, Ph.D., LightSolver
  • James Butler, Ph.D., Hamamatsu
  • Natalie Fardian-Melamed, Ph.D., Columbia University
  • Justin Sigley, Ph.D., AmeriCOM
  • Professor Birgit Stiller, Max Planck Institute for the Science of Light, and Leibniz University of Hannover
  • Professor Stephen Sweeney, University of Glasgow
  • Mohan Wang, Ph.D., University of Oxford
  • Professor Xuchen Wang, Harbin Engineering University
  • Professor Stefan Witte, Delft University of Technology
My Watchlist
Indicators
Industrial Laser Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

How Compounded Treatments Are Helping Hims & Hers Customers Meet Their Weight Loss Goals

By: via Business Wire

Hims & Hers today released a white paper on how its customers are thriving and seeing meaningful results through personalized weight loss solutions

Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the leading health and wellness platform, today released a white paper entitled “Hims & Hers Weight Loss: A Look at Early Customer Experiences and Outcomes” which outlines how customers are achieving positive outcomes with compounded medications through our weight loss program. Early customer results indicate they are managing side effects well, staying on treatment, and overall feeling healthier.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241029420293/en/

Data from Hims & Hers Weight Loss: A Look at Early Customer Experiences and Outcomes outlines how customers are achieving positive outcomes within our weight loss program. Early customer results indicate they are managing side effects well, staying on treatment, and overall feeling healthier. (Photo: Business Wire)

Data from Hims & Hers Weight Loss: A Look at Early Customer Experiences and Outcomes outlines how customers are achieving positive outcomes within our weight loss program. Early customer results indicate they are managing side effects well, staying on treatment, and overall feeling healthier. (Photo: Business Wire)

The United States is in the midst of an obesity epidemic. 70% of American adults have obesity or are overweight. According to the World Health Organization (WHO), at least 2.8 million people die each year due to being overweight or obese. To help solve the obesity crisis in America, successful weight loss solutions are critical to helping patients prosper. We need weight loss solutions that can meet intense ongoing consumer demand, are cost-effective, and are tailored to individuals’ unique needs and sensitivities.

“We are laser focused on increasing access to world-class personalized care in the highest impact areas of health and wellness,” said Dr. Patrick Carroll, Chief Medical Officer of Hims & Hers. “With over 40% of our nation’s adults considered obese our country demands that we use our expertise, size, and industry leadership to answer the very real obesity crisis in the United States and be a part of the solution for the millions of Americans who have obesity and are looking for help.”

According to data highlighted in the company’s latest white paper, research shows that Hims & Hers weight loss solutions are helping customers achieve positive health outcomes. Key findings include:

  • Customers using oral medication kits on average, lost 7.5 pounds - approximately 3.6% of their initial body weight - in their first month.
  • Customers using compounded GLP-1s lost an average of 9.3 pounds - approximately 4.1% of their initial body weight - in their first month.
  • 79% of compounded GLP-1 customers reported that their treatment experience had met or exceeded their expectations.
  • 90% of compounded GLP-1 customers are satisfied with their personalized dosing plan and 87% reported they are progressing towards their weight loss goal, very close to meeting their weight loss goal, or had already achieved their weight loss goal.

The research also suggests that Hims & Hers’ weight loss offering is sustainable, allowing its customers to stay on their treatments and achieve lasting results.

  • Only 13% of compounded GLP-1 customers cancel their treatment subscription in the first month. This is significant when compared to a recent Blue Cross Blue Shield finding that over 30% of commercially insured adults prescribed GLP-1 treatment discontinue within the first four weeks, which may be because of discomfort with early side effects, the high cost of certain weight loss treatments, and limited access to care.
  • 80% of compounded GLP-1 customers who report side effects like nausea say the side effects are tolerable, indicating they plan to continue their treatment, despite mild side effects.

Since December 2023, Hims & Hers has provided its customers access to weight loss solutions. The Hims & Hers program offers a holistic, cost-effective, and personalized approach to reducing weight that includes:

  • Medication management: Following consultation with a licensed healthcare provider on the platform, patients may be prescribed medication that is personalized based upon individual patients’ weight loss goals, medical history, needs, and preferences.
  • Nutrition, exercise, and mental health support: Through the Hims & Hers app, patients have access to educational and motivational content that offers nutrition guidance, recipes, exercise recommendations, sleep advice, and mental health support. All content is personalized based on the individual’s lifestyle and appetite profile.
  • Digital tracking tools: Through the Hims & Hers app, patients can track their progress, hydration, movement, and sleep.
  • 24/7 access to a care team: Individuals can message their care team at any time through the Hims & Hers app.

“The data and insights we have been able to glean through our research show that our customers are having meaningful health outcomes when it comes to weight loss,” said Dr. Jessica Yu, Senior Director of Patient Experience at Hims & Hers. “The data shows our customers are experiencing good weight loss on compounded medications, having manageable side-effects through personalized dosing, suggesting the treatment is sustainable and they are making positive strides towards a healthier future. The importance of these findings is significant as we believe early customer satisfaction and adherence to treatment is likely to enhance long-term outcomes and even more important as we continue to search for ways to manage the obesity crisis in our nation.”

Download the full white paper here.

Contacts

More News

View More
3 Healthcare Stocks Using AI to Drive Growth
Via MarketBeat
Topics Artificial Intelligence
Tickers BSX HIMS TEM
Get Exposure to Millennials' Purchasing Power With This ETF
Via MarketBeat
Topics ETFs
Tickers AAPL DASH DIS GOOGL META MILN
Why a $4.5 Billion Smart Debt Move Is Fueling Dell’s AI Ambitions
Via MarketBeat
Topics Artificial Intelligence
Tickers DELL
Beam Global Gets Buy Rating With 101% Upside Potential
Via MarketBeat
Topics Intellectual Property
Tickers BEEM
These 3 Crypto Stocks Could Get a Bump as Dollar Trust Weakens
Via MarketBeat
Topics ETFs Economy World Trade
Tickers BITF COIN HOOD
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.